Document is current
Any future updates will be listed below
-
Authors
Wei, Alexander Z. https://orcid.org/0000-0003-3290-9959
Maniar, Ashray B.
Carvajal, Richard D. https://orcid.org/0000-0002-3796-1118
- License Information
-
More Information
Article History
Received: 6 October 2021
Revised: 14 January 2022
Accepted: 8 February 2022
First Online: 2 March 2022
Competing interests
: RDC serves as a consultant and/or advisory board member for AstraZeneca, Aura Biosciences, Iconic Therapeutics, Janssen, Merck, Novartis, Rgenix, and Thomson Reuter. The remaining authors declare no competing interests.
